MesmerEyez Coloured Contact Lenses

Healthcare & Medical • United Kingdomwww.colouryoureyes.com

Review data last updated August 11, 2026.

Request Custom AnalysisSign up free to see everything

Based on public reviews and response behavior.

Overall Score

63/100

4.10 ★ average rating · 600 reviews

Competitive Performance Rank

Among fully-analyzed Healthcare & Medical companies

#151of 615

Top 25% · Top Tier

#1 (best)#615 (worst)

#149Peer

#150Peer

#151This company

#152Peer

#153Peer

Overall Customer Sentiment

Category Leader

72% of reviews positive, 27% negative

72%

positive

Positive72%
Neutral1%
Negative27%

Sentiment Balance

Covering January 2024 — 3 reviews, not the company's full review history.

Positive sentiment

Neutral sentiment

Negative sentiment

—

positive

Positive—
Neutral—
Negative—

Takeaway: Positive sentiment accounts for 100% of reviews in this period, with 0% negative and 0% neutral.

Sentiment Trend Over Time

Reviews (Count)

Showing 580 reviews across the months with enough data to chart reliably (min 3/month), most recent: January 2024.

Sentiment has been improving over the period shown.

Theme Distribution

Share of theme mentions

Delivery Shipping

19.8%

Product Quality

17.1%

Communication

13.9%

Loyalty

13.2%

Response Speed

11.6%

Most feedback concerns Delivery Shipping.

Churn Signal Score

Rule-based: negative-review share, churn-intent phrases, and sentiment movement over time.

MEDIUM44/100

44/100

signal score

•Built from a negative-review share of 31.7% across this company's analyzed reviews.
•6 reviews contain phrases that signal intent to leave, such as cancelling or switching provider.
•The share of negative reviews has held steady over time, so the trend doesn't move the score.

Reviewer Breakdown

Star split and recent-versus-earlier sentiment.

4.1avg rating

5★

70.8%

4★

6.0%

3★

2.8%

2★

2.7%

1★

17.7%

Based on 600 analyzed reviews. Sentiment is holding steady: 100.0% of reviews in the last three months were positive, compared with 100.0% in the three months before that.

Unlock full insights